Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular Function
University of Minnesota · NCT06490146
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 45–55 · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- April 1, 2025
- Record last updated
- May 20, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a longitudinal study to determine the influence of the menopause transition on autonomic and vascular function. PI Keller-Ross has published data demonstrating that postmenopausal females have greater sympathetic neural reactivity during a stressor compared with age-matched males and younger females and males. A paucity of literature exists, however, on the role of the menopause transition in autonomic function because the majority of experimental studies on menopause physiology are cross-sectional and/or focused on older, postmenopausal females .
The influence of age on HTN is robust, whereas the effects of menopause are still unclear. Preliminary data demonstrate a clear association between age and sympathetic activity in females; how the transition through menopause influences these relations, however, remains unknown. The study will enroll 80 midlife (45-55 years of age) females to measure longitudinally the trajectory of autonomic and vascular function during the transition through menopause. The study hypothesizes that through the menopause transition, an increase in sympathetic activity and an impaired baroreflex sensitivity and endothelial function will emerge.
Being studied: No intervention
Conditions: Menopause
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Female
- age 45-55 years
- premenopausal
- not using any medications determined to affect autonomic function
- eumenorrheic
- not planning to become pregnant for the duration of participation in the study
- English-speaking, literate, willing and able to provide informed consent.
Exclusion Criteria
- Diabetes
- pregnant or breastfeeding
- cardiac or pulmonary disorders
- severe obesity (body mass index [BMI] ≥ 40 kg/m 2 )
- hypertension
- obstructive sleep apnea
- current use of heart or blood pressure medications, current use of hormonal contraceptives or other forms of exogenous sex hormones
- report of nicotine/tobacco use in the last six months, report of current alcohol abuse,
- history of treatment with chemotherapy/radiation
- coagulopathy disorders and/or use of anticoagulant medications, and current use of anxiolytics and/or antidepressants.
Recruiting US locations
University of Minnesota
Minneapolis, MN 55414
Site contact: Emma Lee · menopause@umn.edu
Study contacts (from the official record)
- Emma Lee, PhD · 612-301-8617 · menopause@umn.edu
Similar studies in Minnesota
All women’s health studies in Minnesota →- Recruiting
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Valencia Technologies Corporation
- Location
- Woodbury, MN + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women
Azure Biotech Inc.
- Location
- Saint Paul, MN
- Eligibility basics
- Ages 45–60 · Women only
- Recruiting
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
MedtronicNeuro
- Location
- Rochester, MN + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Time-Efficient Inspiratory Muscle Strength Training for Reducing Sympathetic Activity and Improving Sleep in Midlife Women
Mayo Clinic
- Location
- Rochester, MN
- Eligibility basics
- Ages 45–60 · Women only